| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 17 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 17 |
| 2 | PREDNISOLONE | 17 |
| 3 | PREDNISOLONE ORAL | 17 |
| 4 | PREDNISOLONE ORAL SOLUTION | 17 |
| 5 | PREDNISONE | 13 |
| 6 | FUROSEMIDE | 12 |
| 7 | TACROLIMUS | 10 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 9 |
| 9 | TACROLIMUS OINTMENT 0.1% | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUCYTOSINE | 1 | 0.0007 |
| 1 | WHITE PETROLATUM | 1 | 0.0007 |
| 2 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 3 | GANCICLOVIR SODIUM | 6 | 0.0006 |
| 4 | PREDNISOLONE SODIUM PHOSPHATE | 1 | 0.0004 |
| 5 | SKIN PROTECTANT | 1 | 0.0004 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| 7 | DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | 1 | 0.0003 |
| 8 | ATOVAQUONE | 2 | 0.0002 |
| 9 | AMPHOTERICIN B | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 2 | Antimalarial [EPC] | 2 | 0.0002 |
| 3 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 4 | Anticholinergic [EPC] | 3 | 0.0002 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 6 | Oxazolidinone Antibacterial [EPC] | 4 | 0.0001 |
| 7 | Vitamin K [EPC] | 1 | 0.0001 |
| 8 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |